Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique

被引:124
作者
Gohel, M
Patel, M
Amin, A
Agrawal, R
Dave, R
Bariya, N
机构
[1] LM Coll Pharm, Ahmadabad 380009, Gujarat, India
[2] Shree SK Patel Coll Pharmaceut Educ & Res, Kherva 382711, Mehsana, India
关键词
mouth dissolve tablet; nimesulide; camphor; factorial design; contour plot;
D O I
10.1208/pt050336
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this research was to develop mouth dissolve tablets of nimesulide. Granules containing nimesulide, camphor, crospovidone, and lactose were prepared by wet granulation technique. Camphor was sublimed from the dried granules by exposure to vacuum. The porous granules were then compressed. Alternatively, tablets were first prepared and later exposed to vacuum. The tablets were evaluated for percentage friability, wetting time, and disintegration time. In the investigation, a 3(2) full factorial design was used to investigate the joint influence of 2 formulation variables: amount of camphor and crospovidone. The results of multiple linear regression analysis revealed that for obtaining a rapidly disintegrating dosage form, tablets should be prepared using an optimum concentration of camphor and a higher percentage of crospovidone. A contour plot is also presented to graphically represent the effect of the independent variables on the disintegration time and percentage friability. A checkpoint batch was also prepared to prove the validity of the evolved mathematical model. Sublimation of camphor from tablets resulted in superior tablets as compared with the tablets prepared from granules that were exposed to vacuum. The systematic formulation approach helped in understanding the effect of formulation processing variables.
引用
收藏
页数:6
相关论文
共 19 条
[1]  
Banker GS, 1988, PHARM DOSAGE FORMS D, V1, P427
[2]  
Bi YX, 1996, CHEM PHARM BULL, V44, P2121
[3]  
Bolton S, 1990, PHARM STAT, P234
[4]  
CHANG R, 2000, PHARM TECHNOLOGY N A, P52
[5]   Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug [J].
Corveleyn, S ;
Remon, JP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 152 (02) :215-225
[6]  
DAPINO P, 1994, RESPIRATION, V61, P336
[7]  
Heinemann H., 1975, U.S. Patent, Patent No. [3,885,026, 3885026]
[8]  
Knistich A, 1979, US patent, Patent No. [4134843, 4 134 843]
[9]   New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material [J].
Koizumi, K ;
Watanabe, Y ;
Morita, K ;
Utoguchi, N ;
Matsumoto, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 152 (01) :127-131
[10]   NEW TABLET DISINTEGRATING AGENT - CROSSLINKED POLYVINYLPYRROLIDONE [J].
KORNBLUM, SS ;
STOOPAK, SB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (01) :43-49